32 completed, 2 terminated, 1 not yet recruiting, 1 unknown. 37 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 37 | Completed 32, Terminated 2, Not yet recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 3 |
Follow Cellulitis: new trials by email Literature Review of Cellulitis trials Research Report on Cellulitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naproxen Versus Placebo as Adjunct Treatment of Cellulitis enteric-coated naproxen, Cephalexin Tablets, Placebo - Cellulitis, Skin Disease, Infectious | Phase 3 | Not yet recruiting | Ottawa Hospital Research Institute | 884 | 2026-11-01 | 2026-10-20 |
| Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis Candicort®, Nizoral®, Baycuten N® - Tinea | Phase 3 | Completed | Ache Laboratorios Farmaceuticos S.A. | 125 | 2019-06-11 | 2021-09-20 |
| The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. iontophoresis + caffeine - Caffeine, Cellulitis | Phase 2 / Phase 3 | Completed | Universidade Norte do Paraná | 30 | 2018-06-14 | 2019-04-16 |
| Cantharidin Application in Molluscum Patients-1 VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 266 | 2018-03-21 | 2022-01-11 |
| Cantharidin Application in Molluscum Patients VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 262 | 2018-02-14 | 2021-12-14 |
| Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination Alcohol, No alcohol - Skin Infection | Phase 3 | Unknown | University of Toronto | 170 | 2017-05-01 | 2017-05-02 |
| Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections sodium fusidate, linezolid - Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Completed | Arrevus Inc. | 716 | 2015-11-01 | 2019-04-19 |
| Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. Ceftaroline fosamil, Vancomycin, Aztreonam - Complicated Skin and Soft Tissue Infection | Phase 3 | Terminated | Pfizer | 4 | 2014-06-01 | 2017-09-06 |
| Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Dalbavancin, Dalbavancin-matching Placebo - Abscess, Wound Infection | Phase 3 | Completed | Durata Therapeutics Inc., an affiliate of Allergan plc | 698 | 2014-04-18 | 2018-09-28 |
| Evaluation of the Activity of a Pharmacological "Anticellulitis" Product vs. a Reference Product on the Market ANTICELLULITE GMG GIULIANI Cream and SOMATOLINE Cream - Healthy | Phase 3 | Completed | Derming SRL | 22 | 2013-09-01 | 2014-07-21 |
| Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Delafloxacin, Vancomycin, Aztreonam - Skin and Subcutaneous Tissue Bacterial Infections | Phase 3 | Completed | Melinta Therapeutics, Inc. | 660 | 2013-04-01 | 2017-09-27 |
| Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections Ceftaroline fosamil, Vancomycin, Aztreonam - Complicated Skin and Soft Tissue Infection | Phase 3 | Completed | Pfizer | 802 | 2012-05-01 | 2017-09-06 |
| Evaluation of Novel Antimicrobial Hand Towels Antimicrobial Hand Towel - Diarrheal Diseases, Acute Respiratory Infections | Phase 2 / Phase 3 | Completed | Centers for Disease Control and Prevention | 449 | 2012-03-01 | 2015-07-31 |
| Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections IV Dalbavancin, Vancomycin/Linezolid - Abscess, Wound Infection | Phase 3 | Completed | Durata Therapeutics Inc., an affiliate of Allergan plc | 739 | 2011-07-01 | 2014-02-12 |
| Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Dalbavancin, Vancomycin / Linezolid - Abscess, Wound Infection | Phase 3 | Completed | Durata Therapeutics Inc., an affiliate of Allergan plc | 573 | 2011-03-01 | 2014-01-31 |
| Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I) Single-Dose IV Oritavancin Diphosphate, IV Vancomycin, Placebo - Wound Infection, Abscess | Phase 3 | Completed | Melinta Therapeutics, Inc. | 968 | 2010-12-01 | 2022-08-01 |
| Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Single-Dose IV Oritavancin Diphosphate, IV Vancomycin - Wound Infection, Abscess | Phase 3 | Completed | Melinta Therapeutics, Inc. | 1019 | 2010-12-01 | 2021-05-05 |
| Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections Daptomycin, Vancomycin or Semi-Synthetic Penicillins (SSPs) - Infections | Phase 3 | Completed | Novartis Pharmaceuticals | 120 | 2010-03-01 | 2012-07-13 |
| Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) PTK 0796, Linezolid - Skin Structures and Soft Tissue Infections | Phase 3 | Withdrawn | Paratek Pharmaceuticals Inc | 2009-07-01 | 2012-05-09 | |
| Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) PTK 0796, linezolid, moxifloxacin - Skin Diseases, Infectious | Phase 3 | Terminated | Paratek Pharmaceuticals Inc | 143 | 2009-04-04 | 2021-03-12 |
Showing 20 of 37. Sign in to see all of them.
Abscess (12) · Wound Infection (8) · Bacterial Infections (7) · Infections (6) · Skin Diseases, Bacterial (6) · Skin Diseases (5) · Soft Tissue Infections (5) · Surgical Wound Infection (5) · Skin Diseases, Infectious (4) · Staphylococcal Infections (3) · Communicable Diseases (2) · Impetigo (2) · Molluscum Contagiosum (2) · Poxviridae Infections (2)
Connective Tissue Diseases (37) · Inflammation (37) · Pathologic Processes (37) · Pathological Conditions, Signs and Symptoms (37) · Skin and Connective Tissue Diseases (37) · Suppuration (37) · Skin Diseases, Infectious (33) · Infections (31) · Bacterial Infections and Mycoses (13) · Skin Diseases (11) · Bacterial Infections (5) · Gram-Positive Bacterial Infections (5) · Postoperative Complications (5) · Disease Attributes (3) · DNA Virus Infections (2)
Vancomycin (12) · Aztreonam (6) · Linezolid (6) · Ceftaroline (4) · Moxifloxacin (3) · dalbavancin (3) · 7-dimethylamino-9-(2,2-dimethylpropyl)aminomethylcycline (2) · Daptomycin (2) · Levofloxacin (2) · Tigecycline (2) · VP-102 (2) · Caffeine (1) · Calcium Dobesilate (1) · Cefazolin (1) · Cephalexin (1)
Durata Therapeutics Inc., an affiliate of Allergan plc (3) · Melinta Therapeutics, Inc. (3) · Pfizer (3) · Arpida AG (2) · Forest Laboratories (2) · GlaxoSmithKline (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Paratek Pharmaceuticals Inc (2) · Verrica Pharmaceuticals Inc. (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · 59th Medical Wing (1) · Ache Laboratorios Farmaceuticos S.A. (1) · Arrevus Inc. (1) · AstraZeneca (1) · Centers for Disease Control and Prevention (1)
United States (21) · Russia (9) · Brazil (8) · Ukraine (8) · Germany (7) · Poland (7) · South Africa (7) · Argentina (6) · Canada (6) · Croatia (6) · Romania (6) · Chile (5) · Latvia (5) · Mexico (5) · Spain (5)
David Melnick, MSD (2) · G. Ralph Corey, MD (2) · Lawrence Eichenfield, MD (2) · Michael Dunne, MD (2) · Adele Sparavigna, Doctor (1) · Anna Taddio, PhD (1) · Jared Spotkov, M.D. (1) · Karen Atkin (1) · Krishan Yadav, MD, MSc (1) · Loren Miller, M.D., M.P.H. (1) · Mark Wilcox, MD (1)
PMID 30597021, PMID 30716446, PMID 34741280, PMID 34905144, PMID 34922058, PMID 20695801, PMID 21115456, PMID 24897082, PMID 27370913, PMID 27585969, PMID 29358292, PMID 32965495, PMID 33599960, PMID 34976290, PMID 12145720, PMID 19036671, PMID 19220646, PMID 20346539, PMID 21115454, PMID 21115455, PMID 24010809, PMID 24439136, PMID 24897083, PMID 25294250, PMID 25396674, PMID 26611777, PMID 28630189, PMID 29029278, PMID 30349845, PMID 30380060, PMID 30797084, PMID 32607967
2009 (1)